High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
Phase of Trial: Phase IV
Latest Information Update: 11 Dec 2015
At a glance
- Drugs Lurasidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 08 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2014 Planned primary completion date changed from 1 Dec 2014 to 1 May 2015 as reported by ClinicalTrial.gov.
- 18 Feb 2014 Planned End Date changed from 1 Apr 2014 to 1 Dec 2014 as reported by ClinicalTrial.gov.